Core Laboratories (CLB) Gross Profit (2022 - 2026)

Core Laboratories has reported Gross Profit for 5 years, with the latest figure at $95.8 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit fell 1.29% year-over-year to $95.8 million; the trailing twelve-month figure through Mar 2026 stood at $178.2 million (down 43.36% YoY), and the FY2025 full-year result was $224.3 million, down 0.98% from the prior year.
• Gross Profit for Q1 2026 stood at $95.8 million, up from -$77.8 million in the prior quarter.
• The five-year high for Gross Profit was $212.9 million in Q4 2022, with the low at -$77.8 million in Q4 2025.
• Historically, Gross Profit has averaged $86.4 million across 5 years, with a median of $97.4 million in 2023.
• Annual changes were most pronounced in 2023 — Gross Profit rose 8.34% — and 2025, when it slumped 238.69%.
• Core Laboratories' Gross Profit stood at $212.9 million in 2022, then plunged by 54.05% to $97.8 million in 2023, then plunged by 42.63% to $56.1 million in 2024, then tumbled by 238.69% to -$77.8 million in 2025, then soared by 223.17% to $95.8 million in 2026.
• The last three Gross Profit figures came in at $95.8 million (Q1 2026), -$77.8 million (Q4 2025), and $59.6 million (Q3 2025), per Business Quant data.